Jack Ball

Board of Directors Member

Mr. Ball brings a strong track record of life sciences leadership and a strong background in commercial operations in the life sciences. Currently, he leads Solulink, Inc. as its Chief Executive Officer. Solulink is a life sciences tools company that develops, manufactures, and markets proprietary next generation linking technologies. Mr. Ball is also President of Tyball Associates, LLC, and an Adjunct Professor at the University of Michigan, Ross Business School in Entrepreneurial Studies.

Previously, Mr. Ball served as Chief Commercial Officer of Accuri Cytometers, Inc. from the commercialization of its first product through its acquisition by BD Biosciences in 2011. Prior to joining Accuri, he was CEO of Amnis Corporations. Mr. Ball also served as Chief Commercial Officer for Molecular Probes, Inc. (acquired by Life Technologies). Prior to Molecular Probes, Mr. Ball was the Senior VP & General Manager of the Life Sciences Group at Orchid Biosciences, and a senior executive at Amersham Pharmacia Biotech Inc., where he rose to President, North America. Mr. Ball also serves on the board of directors of several life science companies, including Swift Biosciences, ViroCyt, NanoCellect, Wasatch Microfluidics, ENT Biotech Solutions, DNA Software and CelSee Diagnostics, as well as the non-profit organization the Association of Commercial Professionals (ACP-LS).